Skip to main content
Fig. 9 | BMC Medical Genomics

Fig. 9

From: CYP19A1 promotes gastric cancer as part of a lipid metabolism-related gene signature related to the response of immunotherapy and prognosis

Fig. 9

Immunotherapeutic responses in two risk groups. Notes: A The correlation between risk score and immune and ESTIMATE scores was estimated. B The difference in TIDE, Dysfunction, and Exclusion scores between patients in high and low risk groups was analyzed. C A larger percentage of patients in the high-risk group responded to immunotherapy than those in the low-risk group. D The immunotherapy targeting CTLA4 receptors was observed to be effective for patients with high hazards. E The effectiveness of clinical immunotherapy in patients between two risk groups was compared

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us